Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Kathryn P Gray, Ph.D.

Concepts (278)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Neoplasm Recurrence, Local14202092400.480 Why?
Antineoplastic Combined Chemotherapy Protocols142020115250.450 Why?
HIV-110202369390.380 Why?
Androgen Antagonists5201813770.340 Why?
Models, Statistical3200851010.320 Why?
Carcinoma, Renal Cell6201931430.300 Why?
HIV Seropositivity220239710.280 Why?
Prostatic Neoplasms102018111260.270 Why?
Patient Dropouts120084210.260 Why?
Aromatase220161470.260 Why?
Breast Neoplasms112020208230.240 Why?
Nitriles420209550.230 Why?
HIV Infections122023167150.230 Why?
Disease-Free Survival6201968960.230 Why?
Survival Analysis72019102520.220 Why?
Proto-Oncogene Proteins c-met220205780.220 Why?
Receptors, Estrogen4202021900.220 Why?
PTEN Phosphohydrolase2201811420.220 Why?
Kaplan-Meier Estimate12202065390.210 Why?
Receptors, Androgen2202010580.210 Why?
Estrogen Receptor alpha220165770.210 Why?
Lymphocytes, Tumor-Infiltrating2201910380.200 Why?
Cytidine Deaminase220142520.200 Why?
Ritonavir220083220.200 Why?
Tamoxifen320169810.200 Why?
Viral Load6200833000.190 Why?
HIV Integrase Inhibitors120221420.180 Why?
Antineoplastic Agents, Hormonal5201815240.180 Why?
Central Nervous System Diseases320135180.180 Why?
Anti-HIV Agents4202342550.170 Why?
Neoplasm Metastasis6201948510.160 Why?
Triazoles220159100.160 Why?
Retinoblastoma Binding Proteins12018980.160 Why?
HIV Protease Inhibitors320084300.160 Why?
RNA, Viral6202329010.160 Why?
Radium12018650.150 Why?
Testicular Neoplasms220148060.150 Why?
Antiretroviral Therapy, Highly Active3200718720.150 Why?
Kidney Neoplasms3201942620.150 Why?
Mannose-Binding Lectin120081500.150 Why?
DNA Topoisomerases, Type II120171210.150 Why?
Randomized Controlled Trials as Topic4201699570.140 Why?
Gene Fusion120193710.140 Why?
Bone Diseases120204160.140 Why?
Secretory Leukocyte Peptidase Inhibitor12016230.140 Why?
DNA Mismatch Repair120194260.140 Why?
Reverse Transcriptase Inhibitors220046150.140 Why?
Cancer Care Facilities120194020.140 Why?
Postmenopause3202024600.130 Why?
Data Interpretation, Statistical1200627160.130 Why?
Taxoids220196660.130 Why?
Cystadenocarcinoma, Serous120194500.130 Why?
Colonic Polyps120205420.130 Why?
Ovary220189810.130 Why?
Chemotherapy, Adjuvant7201834800.130 Why?
Estrogen Receptor beta120151750.130 Why?
Receptors, Progesterone2201810980.120 Why?
Mortality1200628640.120 Why?
Middle Aged3520202133880.120 Why?
Cyclophosphamide2201622420.110 Why?
Insulin-Like Growth Factor Binding Protein 1120131230.110 Why?
Dideoxynucleosides120031220.110 Why?
Bone Density Conservation Agents120207720.110 Why?
Prostatectomy2201818900.110 Why?
Methotrexate2201617280.110 Why?
Neoplasm Staging82019110310.110 Why?
Colonoscopy1202013670.110 Why?
Pyridones320237120.110 Why?
Seminoma120131390.110 Why?
Prognosis122020290600.110 Why?
Aged2720201632840.110 Why?
Tablets220231450.100 Why?
Orchiectomy220144740.100 Why?
Prostate-Specific Antigen6201924940.100 Why?
Chemokine CCL2120146190.100 Why?
Humans5620237443760.100 Why?
Retroperitoneal Neoplasms120143400.100 Why?
Interleukin-8120146900.100 Why?
Androgens2201612810.090 Why?
Prostate1201817750.090 Why?
Alleles4201569330.090 Why?
Endometrial Neoplasms1201913510.090 Why?
Polymorphism, Single Nucleotide52020155200.090 Why?
Adenoma1202021740.090 Why?
Female3520223802000.090 Why?
Survival Rate62020127880.090 Why?
Neoplasms, Germ Cell and Embryonal120145010.080 Why?
Ubiquitin-Protein Ligases1201818620.080 Why?
Phenylthiohydantoin220201930.080 Why?
Antibiotics, Antineoplastic120136920.080 Why?
Pyrones12008360.080 Why?
Estrogens1201615660.080 Why?
Tumor Suppressor Protein p531201829490.080 Why?
Sarcoma1201918970.080 Why?
Disease Progression62019132850.080 Why?
Male3220223501180.080 Why?
Mutation52020297860.080 Why?
Aged, 80 and over122020577760.070 Why?
Polyethylene Glycols1201311820.070 Why?
Adenocarcinoma2201563640.070 Why?
Vascular Endothelial Growth Factor A1201835110.070 Why?
HIV1200416040.070 Why?
Treatment Outcome132020631150.070 Why?
Uterine Cervical Neoplasms1201920200.070 Why?
CD4 Lymphocyte Count4200725600.070 Why?
TOR Serine-Threonine Kinases1201621100.070 Why?
Adult2020232140560.070 Why?
Doxorubicin1201322340.070 Why?
Genotype62018129520.070 Why?
Follow-Up Studies82020390520.070 Why?
Bone Neoplasms1201825300.070 Why?
Tumor Burden3201819150.070 Why?
Tumor Suppressor Proteins1201628500.070 Why?
HLA Antigens1201113820.070 Why?
Likelihood Functions1200810050.060 Why?
Endpoint Determination120086010.060 Why?
Proportional Hazards Models42018123560.060 Why?
Acquired Immunodeficiency Syndrome1200422320.060 Why?
Benzamides2202013790.060 Why?
Mass Screening1202052550.060 Why?
Didanosine120041530.060 Why?
Nucleic Acid Synthesis Inhibitors120041120.060 Why?
Time Factors82019400770.060 Why?
Computer Simulation2200861940.060 Why?
Hot Flashes220163160.060 Why?
Antineoplastic Agents52020136950.060 Why?
Indinavir12003740.060 Why?
Rifabutin12003520.060 Why?
Genetic Association Studies1201227030.060 Why?
Hydroxyurea120042890.060 Why?
Lymph Nodes1201434750.050 Why?
Statistics, Nonparametric1200828870.050 Why?
Ovarian Neoplasms1201948390.050 Why?
Tumor Necrosis Factor-alpha1201444240.050 Why?
Antibodies, Monoclonal1201992740.050 Why?
Adolescent112023857840.050 Why?
Clinical Trials, Phase III as Topic220168410.050 Why?
Lamivudine120233420.050 Why?
Genetic Variation1201665420.050 Why?
Risk Factors82020722950.050 Why?
Feasibility Studies2202350770.050 Why?
Colorectal Neoplasms1202067730.050 Why?
Retrospective Studies102020774590.050 Why?
Oxazines120222980.050 Why?
Poland120201840.050 Why?
Piperazines2202224880.050 Why?
Austria120202030.050 Why?
Heterocyclic Compounds, 3-Ring120222150.050 Why?
Estradiol2201820200.040 Why?
Drug Administration Schedule3201949330.040 Why?
Gene Expression Regulation, Neoplastic4201784320.040 Why?
Protein Kinase Inhibitors1201655350.040 Why?
Combined Modality Therapy3201886420.040 Why?
Aging1200886630.040 Why?
Diamines12019590.040 Why?
Odds Ratio3201898490.040 Why?
Child82023777080.040 Why?
Clinical Trials, Phase I as Topic120193230.040 Why?
Infant52022351340.040 Why?
Cohort Studies62019405580.040 Why?
MAP Kinase Kinase Kinases120192610.040 Why?
Drug Therapy, Combination4200864890.040 Why?
Sensitivity and Specificity22014147230.040 Why?
Young Adult62023564340.040 Why?
Phthalazines120193630.040 Why?
High-Throughput Nucleotide Sequencing2202035960.040 Why?
Incidence22020209500.040 Why?
Pyrimidinones120193710.040 Why?
Tissue Array Analysis120185530.040 Why?
Radioisotopes120185000.040 Why?
Anthracyclines120192880.040 Why?
Indazoles120182900.040 Why?
Pyridines1200828250.040 Why?
Lymphocyte Count120197930.040 Why?
Morpholines120195710.030 Why?
Medical Oncology1200822670.030 Why?
Lymphatic Metastasis2201429240.030 Why?
Sweating120161230.030 Why?
Child, Preschool52022410050.030 Why?
Neoplasms, Hormone-Dependent120184150.030 Why?
Aminopyridines120195420.030 Why?
Risk Assessment42020233360.030 Why?
Drug Synergism1201917970.030 Why?
Estrone120162400.030 Why?
Up-Regulation2201442220.030 Why?
Body Mass Index12012127200.030 Why?
Premenopause1201810330.030 Why?
Sulfonamides2201819400.030 Why?
Bone Remodeling120185750.030 Why?
Software1200844420.030 Why?
Fluorescent Antibody Technique1201825050.030 Why?
Androstadienes120163450.030 Why?
Genes, Tumor Suppressor1201810970.030 Why?
Chromosome Aberrations1202018130.030 Why?
Follicle Stimulating Hormone120167440.030 Why?
Minor Histocompatibility Antigens120142980.030 Why?
Oligopeptides1201811890.030 Why?
Luteinizing Hormone120168690.030 Why?
Anti-Retroviral Agents1202317140.030 Why?
Estrogen Receptor Modulators12012610.030 Why?
Registries2201980910.030 Why?
Early Detection of Cancer2201730860.030 Why?
Gonadotropin-Releasing Hormone1201812060.030 Why?
Gene Expression Profiling2201994450.030 Why?
Colon1202017720.030 Why?
Forkhead Transcription Factors1201916130.030 Why?
Research Design1200859860.030 Why?
RNA1202227490.030 Why?
Haplotypes1200827790.030 Why?
Tomography, X-Ray Computed12014201300.020 Why?
Microarray Analysis120147670.020 Why?
DNA, Neoplasm1201617580.020 Why?
Proto-Oncogene Proteins c-akt1201925040.020 Why?
Cell Line, Tumor22017166920.020 Why?
Obesity12012127450.020 Why?
Predictive Value of Tests22019150780.020 Why?
Signal Transduction32019234060.020 Why?
Antiviral Agents1202229870.020 Why?
Transcriptional Activation1201617830.020 Why?
Liposomes120137590.020 Why?
Logistic Models22018134090.020 Why?
Metabolic Diseases120166580.020 Why?
DNA Mutational Analysis1201841850.020 Why?
Virus Replication1200725350.020 Why?
Pyrazoles1201919720.020 Why?
Aromatase Inhibitors120124900.020 Why?
Intercellular Signaling Peptides and Proteins1201616770.020 Why?
Repressor Proteins1201930240.020 Why?
Risk-Taking120049860.020 Why?
Genetic Predisposition to Disease22020174450.020 Why?
Neoadjuvant Therapy1201827270.020 Why?
Mastectomy, Segmental120139560.020 Why?
Radiographic Image Interpretation, Computer-Assisted1201411840.020 Why?
Lymph Node Excision1201312610.020 Why?
Adiponectin1201311010.020 Why?
Algorithms12008138820.020 Why?
Case-Control Studies22018217470.020 Why?
Double-Blind Method22015120250.020 Why?
Nephrectomy1201210500.020 Why?
United States32020698690.020 Why?
Pyrimidines1201829430.020 Why?
Immunohistochemistry12019113660.020 Why?
Alanine Transaminase120085920.020 Why?
Dose-Response Relationship, Drug12018109430.020 Why?
Cell Survival1201658820.020 Why?
Health Services Accessibility1202351350.020 Why?
Leptin1201316000.020 Why?
Blood Coagulation Disorders120083370.020 Why?
Quality of Life22019128030.020 Why?
Vomiting120086370.020 Why?
Computational Biology1201735190.020 Why?
Clinical Competence1202046870.020 Why?
Prospective Studies22019532910.020 Why?
Anti-Bacterial Agents1200371820.020 Why?
Genomics1202057170.020 Why?
Mastectomy1201317930.020 Why?
DNA, Viral1201122270.020 Why?
Regression Analysis1200464590.010 Why?
Lung Neoplasms12008131040.010 Why?
Pain1201849870.010 Why?
Recurrence1201483400.010 Why?
Mice, Knockout12017145610.010 Why?
Models, Biological1201895840.010 Why?
Polymerase Chain Reaction1201161710.010 Why?
Diarrhea1200813480.010 Why?
Cognition1200867700.010 Why?
Cell Proliferation12016104840.010 Why?
RNA, Messenger12014130350.010 Why?
Multivariate Analysis12013122440.010 Why?
Area Under Curve1200316550.010 Why?
Comorbidity12013103880.010 Why?
Genome-Wide Association Study12017122620.010 Why?
Drug Interactions1200314600.010 Why?
Cross-Over Studies1200320290.010 Why?
Infant, Newborn12007256280.010 Why?
Reproducibility of Results12014199050.010 Why?
Mice12017812020.010 Why?
Animals120171687700.000 Why?
Gray's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (278)
Explore
_
Co-Authors (63)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
© 2024 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.